SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) announced that its Board of Directors is conducting a review of strategic options focusing on maximizing shareholder value. The Company has engaged Cantor Fitzgerald & Co. to act as its strategic and financial advisor...